Navigation Links
Taboo Health Concern Facing Young Women On Birth Control
Date:9/18/2012

NEW YORK, Sept. 18, 2012 /PRNewswire/ -- According to the Guttmacher Institute, over ten million women in the US use oral contraceptives. Although birth control pills are an effective way to prevent pregnancy, keep acne at bay, and treat menstrual pain or irregularity, there may be some health concerns that are undisclosed to patients. A recent study suggests that oral contraceptive use can lead to increased pain during intercourse, with decreased libido and spontaneous arousability as well as diminished frequency of sexual intercourse and orgasm in young women.

(Logo:  http://photos.prnewswire.com/prnh/20120717/NY41829 )

Several recent studies indicate that the use of oral contraceptives is associated with a substantially increased risk of developing vestibulodynia. Additionally, oral contraceptives are known to cause perturbations in serum estradiol, free testosterone levels, and hormonal receptors, as well as alter the morphological pattern of the vulvar vestibular mucosa. Some leading researchers are therefore hypothesizing that these changes may induce atrophic changes in the mucosa of the vulvar vestibule, leading to discomfort and pain with sex; similar to menopausal women.

Women suffering from vulvar pain and irritation are not only subject to physical pain, but emotional stress as well. Relationships are often strained as a result of intimacy issues since women will often abstain from sexual intercourse due to the pain it causes. Additionally, it is common for women to experience a decrease in their self-esteem. 

Although there are several products on the market that target vaginal dryness, one in particular helps to not only soothe, but also to restore vulvar skin. NeoGyn Vulvar Soothing Cream uses Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, to help comfort this delicate area and provide some relief for this common condition that is rarely discussed.

About Neogyn®:

Neogyn® Vulvar Soothing Cream is a cosmetic product to help soothe and comfort the vulva. Formulated with Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, the product is non-greasy, fast absorbing and free of color additives, fragrances and analgesics. Recommended by physicians and women's health professionals, Neogyn® has a unique, patent pending blend of naturally balanced proteins that help restore well-being and comfort with twice daily use over a period of at least 6 to 8 weeks.

RELATED LINKS
http://www.neogyn.us


'/>"/>
SOURCE NeoGyn
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bethesda Health Clinic Utilizes Donated MedInformatix EHR for Nine Years
2. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
3. Global Drug Stores and Health and Beauty Stores Market Size and Forecast to 2016
4. Omron Healthcare Announces New Over-The-Counter Electrotherapy Device
5. Health Diagnostic Laboratory, Inc. hosts Town Hall Meeting with Governor Tim Kaine and Senator Mark Warner
6. Beckers Hospital Review Names 100 Hospitals With Great Womens Health Programs
7. Donor Alliance Named Colorados Top Healthcare Company
8. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
9. One Of Colorados Largest Physician Networks Signs Agreement To Join Colorado Health Information Exchange
10. Verizon to Detail Health Care Fraud, Waste & Abuse - The Next Generation at National Association for Medicaid Program Integrity 2012 Conference, Sept. 18
11. Most Read Pharmaceutical and Health Condition News - August 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Summary GBI ... a Key Component of Multichannel Marketing" provides a ... in the digital age. While the pharmaceutical ... advancements, it has been much slower to adopt ... traditional channels and methods. However, the decreasing effectiveness ...
(Date:3/28/2017)... 2017  Orexigen Therapeutics, Inc. (Nasdaq: OREX ... fourth quarter and year ended December 31, 2016. ... progress for Orexigen, beginning with the re-acquisition of the ... March, the team at Orexigen demonstrated remarkable focus, executing ... and strengthened our Company while rewarding us full control ...
(Date:3/28/2017)... and TORONTO , March 28, 2017 ... leading full service medical device development firm, announced today ... Toronto -based medical device industrial design ... serve medtech companies throughout North America ... experienced medical device talent spanning the design, engineering, regulatory, ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as it ... either don’t have access to a health care facility or a pharmacy within 60 minutes ... the United States or for many who are faced with health or personal issues that ...
(Date:3/28/2017)... SEATTLE, Washington and CARTERSVILLE, Georgia (PRWEB) , ... ... ... adding another senior analyst to its award-winning team. Ruel Williamson brings his extensive ... Advisors, which has been a leader in the real estate valuation industry for ...
(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth has ... to protect parental rights and civil liberties, and to restore transparency within government ... demonstration coincides with a press conference taking place Friday morning calling on President ...
(Date:3/28/2017)... ... , ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts ... Secret. Dr. Wentz talked about journey and research recently on a blog and discussed ... the only solution to deal with thyroid disease. , Dr. Wentz completed her ...
(Date:3/28/2017)... ... March 28, 2017 , ... Medforce Technologies, Inc., a leading ... it has joined the National Association for Home Care and Hospice (NAHC), the ... and dying Americans of all ages and the caregiver who provide them with ...
Breaking Medicine News(10 mins):